Cargando…
Roxadustat and thyroid-stimulating hormone suppression
Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression...
Autores principales: | Tokuyama, Atsuyuki, Kadoya, Hiroyuki, Obata, Atsushi, Obata, Takahiro, Sasaki, Tamaki, Kashihara, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087136/ https://www.ncbi.nlm.nih.gov/pubmed/33959275 http://dx.doi.org/10.1093/ckj/sfab007 |
Ejemplares similares
-
Renal cell carcinoma sharply captured by imaging technology at an early stage in a hemodialysis patient: Usefulness of noninvasive monochrome superb microvascular imaging
por: Ohsawa, Rie, et al.
Publicado: (2021) -
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021) -
Minimal change disease soon after Pfizer-BioNTech COVID-19 vaccination
por: Kobayashi, Seiji, et al.
Publicado: (2021) -
Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia
por: Tokuyama, Atsuyuki, et al.
Publicado: (2021) -
Endothelial Dysfunction Accelerates Impairment of Mitochondrial Function in Ageing Kidneys via Inflammasome Activation
por: Wada, Yoshihisa, et al.
Publicado: (2021)